Skip to main content

Jacobs Levy Equity Management, Inc

Source: SEC Form 13F · as of Mar 2026

Jacobs Levy Equity Management, Inc holds 53 biotech & pharma companies tracked by BioSniper, totaling $560.1M in value as of Mar 2026 (SEC Form 13F).

Companies held

53

Total value held

$560.1M

BioSniper AIPage evidence connected

Prepared research question

What matters most for REGENERON PHARMACEUTICALS, INC. (REGN)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
REGNREGENERON PHARMACEUTICALS, INC.214,160$165.5M
INCYIncyte Corp.1,717,978$161.7M
ALNYALNYLAM PHARMACEUTICALS, INC.212,204$70.2M
EXELEXELIXIS, INC.425,982$18.3M
ARVNARVINAS, INC.1,441,521$15.3M
TVTXTravere Therapeutics, Inc.369,193$11.0M
NRIXNurix Therapeutics, Inc.620,820$9.6M
PRTAPROTHENA CORP PUBLIC LTD CO972,017$9.4M
RCUSArcus Biosciences, Inc.430,346$9.3M
KROSKeros Therapeutics, Inc.706,071$7.8M
BIOABioAge Labs, Inc.420,123$7.3M
FLGTFulgent Genetics Inc.356,359$5.7M
MRNAModerna, Inc.99,952$5.1M
KURAKura Oncology, Inc.602,231$4.9M
BBIOBridgeBio Pharma, Inc.63,180$4.7M
ALECAlector, Inc.2,154,361$4.6M
TRDAEntrada Therapeutics, Inc.333,914$4.2M
LGNDLigand Pharmaceuticals Incorporated20,529$4.1M
OCULOCULAR THERAPEUTIX, INC470,029$4.0M
ACADACADIA PHARMACEUTICALS INC142,716$3.2M
DSGNDesign Therapeutics, Inc.289,385$3.1M
APLSApellis Pharmaceuticals, Inc.61,681$2.5M
HRMYHarmony Biosciences Holdings, Inc.82,268$2.3M
SUPNSUPERNUS PHARMACEUTICALS, INC.42,726$2.2M
NKTRNEKTAR THERAPEUTICS30,141$2.2M
DNAGinkgo Bioworks Holdings Inc.322,717$2.0M
ANABANAPTYSBIO, INC28,625$1.6M
SIGASIGA TECHNOLOGIES INC291,846$1.6M
KODKodiak Sciences Inc.40,939$1.6M
RCKTRocket Pharmaceuticals Inc.416,533$1.5M
ALDXAldeyra Therapeutics, Inc.796,816$1.3M
ZYMEZymeworks Inc.42,786$1.1M
LENZLENZ Therapeutics, Inc.117,011$1.1M
AGIOAGIOS PHARMACEUTICALS, INC.28,530$965K
PLRXPLIANT THERAPEUTICS, INC.718,543$905K
ANNXAnnexon, Inc.148,941$825K
NTLAIntellia Therapeutics, Inc.59,983$769K
LRMRLarimar Therapeutics, Inc.169,144$761K
CCCCC4 Therapeutics, Inc.264,620$696K
RZLTRezolute, Inc.220,407$672K
RNACCartesian Therapeutics, Inc.101,534$624K
ZBIOZenas BioPharma, Inc.27,532$538K
MGXMetagenomi Therapeutics, Inc.382,153$512K
SGMOQSANGAMO THERAPEUTICS, INC2,050,384$506K
BMEABiomea Fusion, Inc.310,514$475K
FLNAFilana Therapeutics Inc.209,080$353K
OGNOrganon & Co.58,657$351K
CTMXCytomX Therapeutics, Inc.68,378$321K
JSPRJasper Therapeutics Inc.322,273$282K
BHVNBiohaven Ltd.30,080$254K
LXRXLEXICON PHARMACEUTICALS, INC.130,020$203K
CMPXCompass Therapeutics, Inc.30,655$162K
IMAImageneBio, Inc.26,663$133K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.